Figure 3
From: Bone regeneration in ceramic scaffolds with variable concentrations of PDRN and rhBMP-2
Histomorphometric analysis of new bone formation in response to HA/TCP scaffolds in New Zealand white rabbits 8 weeks post-operation. (a) 0.1 mg/mL PDRN; (b) 1.0 mg/mL PDRN; (c) 5 mg/mL PDRN; (d) 10 mg/mL PDRN; (e) 0.01 mg/mL rhBMP-2; (f) 0.05 mg/mL rhBMP-2; (g) 0.1 mg/mL rhBMP-2; (h) Control group; (white triangle) new bone. PDRN polydeoxyribonucleotide; rhBMP-2 recombinant human bone morphogenic protein; HA hydroxyapatite; TCP tricalcium phosphate.
